Nitric oxide synthase-3 overexpression causes apoptosis and impairs neuronal mitochondrial function: Relevance to Alzheimer's-type neurodegeneration

Laboratory Investigation

Volumn 83, Issue 2, 2003, Pages 287-298

  De la Monte, Suzanne M ^a   Chiche, Jean Daniel ^b   Von dem Bussche, Annette ^a   Sanyal, Sohini ^a   Lahousse, Stephanie A ^a   Janssens, Stephan P ^c   Bloch, Kenneth D ^b  

^a RHODE ISLAND HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOVIRUS VECTOR; COMPLEMENTARY DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FAS ANTIGEN; GREEN FLUORESCENT PROTEIN; NITRIC OXIDE SYNTHASE; PROTEIN BAX; PROTEIN P21; PROTEIN P53; REACTIVE OXYGEN METABOLITE; TETRAZOLIUM REDUCTASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DEMENTIA; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOCHONDRION; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE DEGENERATION; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; VIRUS RECOMBINANT;

EID: 0037329921     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000056995.07053.C0     Document Type: Article

References (59)

1. Ausubel F, Brent R, Kingston R, Moore D, Seidman J, Smith J, and Struhl K, editors (2000). Current protocols in molecular biology. New York: John Wiley & Sons, Inc.
2. Balakirev M, Khramtsov VV, and Zimmer G (1997). Modulation of the mitochondrial permeability transition by nitric oxide. Eur J Biochem 246:710-718.
3. Bernardi P (1996). The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim Biophys Acta 1275:5-9.
4. Boje K and Arora P (1992). Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 587:250-256.
5. Bosca L and Hortelano S (1999). Mechanisms of nitric oxide-dependent apoptosis: Involvement of mitochondrial mediators. Cell Signal 11:239-244.
6. Bredt D and Snyder S (1994). Transient nitric oxide synthase neurons in embryonic cerebral cortical plate, sensory ganglia, and olfactory epithelium. Neuron 13:301-313.
7. Cassarino DS and Bennett JP Jr (1999). An evaluation of the role of mitochondria in neurodegenerative diseases: Mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res Brain Res Rev 29:1-25.
8. Chen PF, Berka V, Tsai AL, and Wu KK (1998). Effects of Asp-369 and Arg-372 mutations on heme environment and function in human endothelial nitric-oxide synthase. J Biol Chem 273:34164-34170.
9. Cotman CW and Su JH (1996). Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol 6:493-506.
10. de la Monte S and Bloch K (1997). Aberrant expression of the constitutive endothelial nitric oxide synthase gene in Alzheimer's disease. Mol Chem Neuropathol 30:139-159.
11. de la Monte SM, Ganju N, Banerjee K, Brown NV, Luong T, and Wands JR (2000a). Partial rescue of ethanol-induced neuronal apoptosis by growth factor activation of phosphoinositol-3-kinase. Alcohol Clin Exp Res 24:716-726.
12. de la Monte SM, Ganju N, Feroz N, Luong T, Bannerjee K, Cannon J, and Wands JR (2000b). Oxygen free radical injury is sufficient to cause some Alzheimer-type molecular abnormalities in human CNS neuronal cells. J Alzheimers Dis 2:261-281.
13. de la Monte SM, Ganju N, and Wands JR (1999). Microtiter immunocytochemical ELISA assay. Biotechniques 26:1073-1076, 1078.
14. de la Monte SM, Lu BX, Sohn YK, Etienne D, Kraft J, Ganju N, and Wands JR (2000c). Aberrant expression of nitric oxide synthase III in Alzheimer's disease: Relevance to cerebral vasculopathy and neurodegeneration. Neurobiol Aging 21: 309-319.
15. de la Monte SM, Luong T, Neely TR, Robinson D, and Wands JR (2000d). Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's Disease. Lab Invest 80:1323-1335.
16. de la Monte SM, Sohn YK, Ganju N, and Wands JR (1998). P53- and CD95-associated apoptosis in neurodegenerative diseases. Lab Invest 78:401-411.
17. de la Monte SM, Sohn YK, and Wands JR (1997). Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci 152:73-83.
18. de la Monte SM and Wands JR (2001). Alzheimer-associated neuronal thread protein-induced apoptosis and impaired mitochondrial function in human central nervous system-derived neuronal cells. J Neuropathol Exp Neurol 60:195-207.
19. Dinerman JL, Dawson TM, Schell MJ, Snowman A, and Snyder SH (1994). Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: Implications for synaptic plasticity. Proc Natl Acad Sci USA 91:4214-4218.
20. Dubowitz V and Brooke MH (1974). Muscle biopsy: A modern approach. Philadelphia: WB Saunders Company Ltd.
21. el-Deiry WS (1997). Role of oncogenes in resistance and killing by cancer therapeutic agents. Curr Opin Oncol 9:79-87.
22. Esiri M and Morris JE (1997). The neuropathology of dementia. Cambridge, United Kingdom: Cambridge University Press.
23. Ghafourifar P and Richter C (1997). Nitric oxide synthase activity in mitochondria. FEBS Lett 418:291-296.
24. Ghafourifar P, Schenk U, Klein SD, and Richter C (1999). Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation. J Biol Chem 274: 31185-31188.
25. Giulivi C, Poderoso JJ, and Boveris A (1998). Production of nitric oxide by mitochondria. J Biol Chem 273:11038-11043.
26. Ham D and Schipper HM (2000). Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides. Cell Mol Biol (Noisy-le-grand) 46:587-596.
27. Hansen MB, Nielsen SE, and Berg K (1989). Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203-210.
28. Hess D, Patterson S, Smith D, and Skene J (1994). Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxide. Nature 366:562-565.
29. Hortelano S, Dallaporta B, Zamzami N, Hirsch T, Susin SA, Marzo I, Bosca L, and Kroemer G (1997). Nitric oxide induces apoptosis via triggering mitochondrial permeability transition. FEBS Lett 410:373-377.
30. Janssens SP, Bloch KD, Nong Z, Gerard RD, Zoldhelyl P, and Collen D (1996). Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats. J Clin Invest 98:317-324.
31. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, and Bloch KD (1992). Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 267:14519-14522.
32. Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, Smith MA, Perry G, Whitehouse PJ, and Taniguchi T (1998). Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res 780:260-269.
33. Klatt P, Heinzel B, John M, Kastner M, Bohme E, and Mayer B (1992). Ca2+/calmodulin-dependent cytochrome c reductase activity of brain nitric oxide synthase. J Biol Chem 267:11374-11378.
34. Klatt P, Schmidt K, Uray G, and Mayer B (1993). Multiple catalytic functions of brain nitric oxide synthase. Biochemical characterization, cofactor requirement, and the role of Nwhydroxy-L-arginine as an intermediate. J Biol Chem 268: 14781-14787.
35. Koch K, Lambrecht H, Haberecht M, Redburn D, and Schmidt H (1994). Functional coupling of a Ca2+/calmodulin dependent nitric oxide synthase and a soluble guanylyl cyclase in vertebrate photoreceptor cells. EMBO J 13:3312-3320.
36. Koprowski H, Zheng Y, Heber-Katz E, Fraser N, Rorke L, Fu A, Hanlon C, and Dietzxchold B (1993). In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci USA 90:3024-3027.
37. Lincoln J, Hoyle CHV, and Burnstock G (1997). Nitric oxide in health and disease, 1st ed. Cambridge: Cambridge University Press.
38. MacGibbon GA, Lawlor PA, Sirimanne ES, Walton MR, Connor B, Young D, Williams C, Gluckman P, Faull RL, Hughes P, and Dragunow M (1997). Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res 750:223-234.
39. McGinnis KM, Gnegy ME, and Wang KK (1999). Endogenous bax translocation in SH-SY5Y human neuroblastoma cells and cerebellar granule neurons undergoing apoptosis. J Neurochem 72:1899-1906.
40. Merrill J, Ignarro L, Sherman M, Melinek J, and Lane T (1993). Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151:2132-2141.
41. Mesenge C, Verrecchia C, Allix M, Boulu R, and Plotkine M (1996). Reduction of the neurological deficit in mice with traumatic brain injury by nitric oxide synthase inhibitors. J Neurotrauma 13:11-16.
42. Moyse E and Michel D (1997). Analysis of apoptosis-associated DNA fragmentation in vivo during neurodegeneration of the peripheral olfactory system in adult mammals. In: Poirier J, editor. Apoptosis techniques and protocols. Neuromethods, vol 29. Totowa, New Jersey: Humana Press, 133-159.
43. Nagy ZS and Esiri MM (1997). Apoptosis-related protein expression in the hippocampus in Alzheimer's disease. Neurobiol Aging 18:565-571.
44. Nishikawa T, Kirsch J, Koehler R, Bredt D, Snyder S, and Traystmann R (1993). Effect of nitric oxide synthase inhibition on cerebral blood flow and injury volume during focal ischemia in cats. Stroke 24:1717-1724.
45. O'Dell TJ, Huang PL, Dawson TM, Dinerman JL, Snyder SH, Kandel ER, and Fishman MC (1994). Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science 265:542-546.
46. Perry G and Nunomura A (1998). Apoptosis and Alzheimer's disease (Letter). Science 282:1268-1269.
47. Picklo MJ, Amarnath V, McIntyre JO, Graham DG, and Montine TJ (1999). 4-Hydroxy-2(E)-nonenal inhibits CNS mitochondrial respiration at multiple sites. J Neurochem 72:1617-1624.
48. Richter C (1992). Reactive oxygen and DNA damage in mitochondria. Mutat Res 275:249-255.
49. Richter C (1995). Oxidative damage to mitochondrial DNA and its relationship to ageing. Int J Biochem Cell Biol 27:647-653.
50. Satou T, Cummings BJ, and Cotman CW (1995). Immunoreactivity for Bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity. Brain Res 697:35-43.
51. Schmidt H and Walter U (1994). NO at work. Cell 78:919-925.
52. Sohn YK, Ganju N, Bloch KD, Wands JR, and de la Monte SM (1999). Neuritic sprouting with aberrant expression of the nitric oxide synthase III gene in neurodegenerative diseases. J Neurol Sci 162:133-151.
53. Stadelmann C, Bruck W, Bancher C, Jellinger K, and Lassmann H (1998). Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis. J Neuropathol Exp Neurol 57:456-464.
54. Su JH, Anderson AJ, Cummings BJ, and Cotman CW (1994). Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5:2529-2533.
55. Su JH, Deng G, and Cotman CW (1997). Bax protein expression is increased in Alzheimer's brain: Correlations with DNA damage, Bcl-2 expression, and brain pathology. J Neuropathol Exp Neurol 56:86-93.
56. The I, Murthy AE, Hannigan GE, Jacoby LB, Menon AG, Gusella JF, and Bernards A (1993). Neurofibromatosis type 1 gene mutations in neuroblastoma. Nat Genet 3:2633-2642.
57. Tortosa A, Lopez E, and Ferrer I (1998). Bcl-2 and Bax protein expression in Alzheimer's disease. Acta Neuropathol (Berl) 95:407-412.
58. Vodovotz Y, Lucia M, Flanders K, Chester L, Xie Q-W, Smith T, Weidner J, Mumford R, Webber R, Nathan C, Roberts AB, Lippa CF, and Sporn MB (1996). Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease. J Exp Med 184:1425-1433.
59. Xu YY, Bhavani K, Wands JR, and de la Monte SM (1995). Insulin-induced differentiation and modulation of neuronal thread protein expression in primitive neuroectodermal tumor cells is linked to phosphorylation of insulin receptor substrate-1. J Mol Neurosci 6:91-108.